-- Recurring revenue grew 10% to $27.6 million, representing 95% of total revenue, with growth across Beamtree’s core Coding, Diagnostics and Knowledge Networks businesses.
Behind these results is a healthcare technology business operating at significant scale. 73% of patient records in Australia are processed through a Beamtree solution, while more than 100 million cases are interpreted through RippleDown each year. Across our products, decades of healthcare data, specialist expertise and long-standing customer relationships have created deep capability and intellectual property that is difficult to replicate.
For CEO Gareth Pye, who joined Beamtree during FY26, this is central to the opportunity ahead:
“What has impressed me most since joining Beamtree is the depth of our healthcare expertise, the strength of our technology and the reach we already have. We have decades of IP, incredibly strong customer relationships, and products that are deeply embedded within healthcare systems. Our opportunity now is to bring greater focus to those strengths and use them to continue to drive sustainable growth in Australia and internationally.”
Beamtree enters FY27 focused on continuing to grow its strong Australian and New Zealand base, progressing targeted opportunities in the UK, Canada and Saudi Arabia, and leveraging its unique IP to develop trusted AI and automation solutions for healthcare.
Click here to read Beamtree’s full FY26 Audited Annual Results.
Release ID: 89202642
Google
RSS